You searched for: systemic exposure (Svenska - Engelska)

exponeringsläge: exposure mode
exposure mode:

exponeringsprogram: exposure program
exposure program:

treatment of systemic sclerosis
• abetimus sodium

poultry antibacterial for systemic use
• poultry • antibacterial for systemic use

treatment of systemic secondary amyloidosis
• treatment of systemic secondary amyloidosis

poultry antibacterial for systemic use qj01ma94)
poultry antibacterial for systemic use (qj01ma94)

enheten stöder inte egenskapen ccd_ exposure.
device does not support ccd_exposure property.

j05ah02 treatment of influenza and post- exposure
j05ah02 treatment of influenza and post- exposure prophylaxis of

cattle & pigs antibacterial for systemic use (qj01ma)
cattle & pigs antibacterial for systemic use (qj01ma)

sirs (systemic inflammatory response syndrome) eller kapillärläckagesyndrom
systemic inflammatory response syndrome (sirs) or capillary leak syndrome

systemic inflammatory response syndrome (sirs) eller kapillärläckagesyndrom:
systemic inflammatory response syndrome (sirs) or capillary leak syndrome:

epa (1992) dermal exposure assessment: principles and applications.
epa, (1992) dermal exposure assessment: principles and applications.

egenskapen ccd_ exposure saknar elementet ccd_ exposure_ value.
ccd_exposure property is missing ccd_exposure_value element.

principles and methods for the assessment of neurotoxicity associated with exposure to chemicals. environmental health criteria document no.
principles and methods for the assessment of neurotoxicity associated with exposure to chemicals.

fastställa en godtagbar användarexponering (aoel, "acceptable operator exposure level(s)"),
establish acceptable operator exposure level(s) (aoel),

"compilation of eu dioxin exposure and health data", av aea technology, england, oktober 1999.
« compilation of eu dioxin exposure and health data », by aea technology, england, october 1999

nbb has recognised that these operations have been undertaken in view of the systemic importance of dexia group […]” [116]
the bnb has recognised that these operations have been undertaken in view of the systemic importance of dexia group …’ [116].

wong, b.a., et al. (1997) developing specialized inhalation exposure systems to address toxicological problems.
wong, b.a., et al., (1997) developing specialised inhalation exposure systems to address toxicological problems.

the residuerestsubstanser i livsmedel av vegetabiliskt ursprung; medlemsstaterna ska bedöma konsumenternas exponering via kosten.s in food of plant origin and evaluate the dietary exposure of consumers,
the residues in food of plant origin and evaluate the dietary exposure of consumers, the protection of bees, non-target arthropods, birds, mammals and aquatic organisms.

fall av allvarliga hypersensitivitetssyndrom inklusive dress (drug rash with eosinophilia and systemic symptoms) (se avsnitt 4. 4).
gastrointestinal disorders frequency unknown: vomiting, abdominal pain, oral mucosal irritation including stomatitis and/ or mouth ulceration skin and subcutaneous tissue disorders frequency unknown: hypersensitivity skin reactions including rash, pruritus, urticaria, angioedema, stevens-johnson syndrome. cases of severe hypersensitivity syndromes including drug rash with eosinophilia and systemic symptoms (dress) (see section 4.4).